<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32338760</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>03</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations.</ArticleTitle><Pagination><StartPage>1547</StartPage><EndPage>1567</EndPage><MedlinePgn>1547-1567</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddaa077</ELocationID><Abstract><AbstractText>Dominant mutations in the mitochondrial paralogs coiled-helix-coiled-helix (CHCHD) domain 2 (C2) and CHCHD10 (C10) were recently identified as causing Parkinson's disease and amyotrophic lateral sclerosis/frontotemporal dementia/myopathy, respectively. The mechanism by which they disrupt mitochondrial cristae, however, has been uncertain. Using the first C2/C10 double knockout (DKO) mice, we report that C10 pathogenesis and the normal function of C2/C10 are intimately linked. Similar to patients with C10 mutations, we found that C2/C10 DKO mice have disrupted mitochondrial cristae, because of cleavage of the mitochondrial-shaping protein long form of OPA1 (L-OPA1) by the stress-induced peptidase OMA1. OMA1 was found to be activated similarly in affected tissues of mutant C10 knock-in (KI) mice, demonstrating that L-OPA1 cleavage is a novel mechanism for cristae abnormalities because of both C10 mutation and C2/C10 loss. Using OMA1 activation as a functional assay, we found that C2 and C10 are partially functionally redundant, and some but not all disease-causing mutations have retained activity. Finally, C2/C10 DKO mice partially phenocopied mutant C10 KI mice with the development of cardiomyopathy and activation of the integrated mitochondrial integrated stress response in affected tissues, tying mutant C10 pathogenesis to C2/C10 function.</AbstractText><CopyrightInformation>Published by Oxford University Press 2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yi-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Inherited Movement Disorders Unit, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xiaoping</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Inherited Movement Disorders Unit, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Inherited Movement Disorders Unit, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shammas</LastName><ForeName>Mario K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Inherited Movement Disorders Unit, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Beverly P</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>Inherited Movement Disorders Unit, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dombi</LastName><ForeName>Eszter</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Springer</LastName><ForeName>Danielle A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Murine Phenotyping Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poulton</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekine</LastName><ForeName>Shiori</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Aging Institute, Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narendra</LastName><ForeName>Derek P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Inherited Movement Disorders Unit, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/J010448/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C554426">CHCHD10 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C547271">Chchd2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D045726">Metalloproteases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="C572960">OMA1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045726" MajorTopicYN="N">Metalloproteases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024101" MajorTopicYN="N">Mitochondrial Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32338760</ArticleId><ArticleId IdType="pmc">PMC7268789</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddaa077</ArticleId><ArticleId IdType="pii">5825277</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ajroud-Driss S., Fecto F., Ajroud K., Lalani I., Calvo S.E., Mootha V.K., Deng H.-X., Siddique N., Tahmoush A.J., Heiman-Patterson T.D. and Siddique T. (2015) Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy. Neurogenetics, 16, 1&#x2013;9. doi: 10.1007/s10048-014-0421-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-014-0421-1</ArticleId><ArticleId IdType="pmc">PMC4796476</ArticleId><ArticleId IdType="pubmed">25193783</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S., Ait-El-Mkadem S., Chaussenot A., Genin E.C., Lacas-Gervais S., Fragaki K., Berg-Alonso L., Kageyama Y., Serre V., Moore D.G. et al. (2014) A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain J. Neurol., 137, 2329&#x2013;2345. doi: 10.1093/brain/awu138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu138</ArticleId><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Funayama M., Ohe K., Amo T., Furuya N., Yamaguchi J., Saiki S., Li Y., Ogaki K., Ando M., Yoshino H. et al. (2015) CHCHD2 mutations in autosomal dominant late-onset Parkinson&#x2019;s disease: a genome-wide linkage and sequencing study. Lancet Neurol., 14, 274&#x2013;282. doi: 10.1016/S1474-4422(14)70266-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70266-2</ArticleId><ArticleId IdType="pubmed">25662902</ArticleId></ArticleIdList></Reference><Reference><Citation>Penttil&#xe4; S., Jokela M., Bouquin H., Saukkonen A.M., Toivanen J. and Udd B. (2015) Late onset spinal motor neuronopathy is caused by mutation in CHCHD10. Ann. Neurol., 77, 163&#x2013;172. doi: 10.1002/ana.24319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24319</ArticleId><ArticleId IdType="pubmed">25428574</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstein S.R., Valsecchi F., Kawamata H., Bourens M., Zeng R., Zuberi A., Milner T.A., Cloonan S.M., Lutz C., Barrientos A. and Manfredi G. (2018) In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions. Hum. Mol. Genet., 27, 160&#x2013;177. doi: 10.1093/hmg/ddx397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx397</ArticleId><ArticleId IdType="pmc">PMC5886281</ArticleId><ArticleId IdType="pubmed">29112723</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Wu B.P., Nguyen D., Liu Y.-T., Marani M., Hench J., B&#xe9;nit P., Kozjak-Pavlovic V., Rustin P., Frank S. and Narendra D.P. (2018) CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10. Hum. Mol. Genet., 27, 3881&#x2013;3900. doi: 10.1093/hmg/ddy270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy270</ArticleId><ArticleId IdType="pmc">PMC6216204</ArticleId><ArticleId IdType="pubmed">30084972</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub I.R., Janer A., Weraarpachai W., Zinman L., Robertson J., Rogaeva E. and Shoubridge E.A. (2018) Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS. Hum. Mol. Genet., 27, 178&#x2013;189. doi: 10.1093/hmg/ddx393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx393</ArticleId><ArticleId IdType="pmc">PMC5886208</ArticleId><ArticleId IdType="pubmed">29121267</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng H., Yamashita C., Shiba-Fukushima K., Inoshita T., Funayama M., Sato S., Hatta T., Natsume T., Umitsu M., Takagi J., Imai Y. and Hattori N. (2017) Loss of Parkinson&#x2019;s disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c. Nat. Commun., 8, 15500. doi: 10.1038/ncomms15500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15500</ArticleId><ArticleId IdType="pmc">PMC5467237</ArticleId><ArticleId IdType="pubmed">28589937</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin E.C., Plutino M., Bannwarth S., Villa E., Cisneros-Barroso E., Roy M., Ortega-Vila B., Fragaki K., Lespinasse F., Pinero-Martos E. et al. (2016) CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis. EMBO Mol. Med., 8, 58&#x2013;72. doi: 10.15252/emmm.201505496.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201505496</ArticleId><ArticleId IdType="pmc">PMC4718158</ArticleId><ArticleId IdType="pubmed">26666268</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W., Ma D., Sun A.X., Tran H.-D., Ma D.-L., Singh B.K., Zhou J., Zhang J., Wang D., Zhao Y. et al. (2019) PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction. Hum. Mol. Genet., 28, 1100&#x2013;1116. doi: 10.1093/hmg/ddy413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy413</ArticleId><ArticleId IdType="pmc">PMC6423417</ArticleId><ArticleId IdType="pubmed">30496485</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies K.M., Strauss M., Daum B., Kief J.H., Osiewacz H.D., Rycovska A., Zickermann V. and K&#xfc;hlbrandt W. (2011) Macromolecular organization of ATP synthase and complex I in whole mitochondria. Proc. Natl. Acad. Sci., 108, 14121&#x2013;14126. doi: 10.1073/pnas.1103621108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1103621108</ArticleId><ArticleId IdType="pmc">PMC3161574</ArticleId><ArticleId IdType="pubmed">21836051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ban T., Ishihara T., Kohno H., Saita S., Ichimura A., Maenaka K., Oka T., Mihara K. and Ishihara N. (2017) Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin. Nat. Cell Biol., 19, 856&#x2013;863. doi: 10.1038/ncb3560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3560</ArticleId><ArticleId IdType="pubmed">28628083</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies K.M., Anselmi C., Wittig I., Faraldo-G&#xf3;mez J.D. and K&#xfc;hlbrandt W. (2012) Structure of the yeast F1Fo-ATP synthase dimer and its role in shaping the mitochondrial cristae. Proc. Natl. Acad. Sci., 109, 13602&#x2013;13607. doi: 10.1073/pnas.1204593109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1204593109</ArticleId><ArticleId IdType="pmc">PMC3427116</ArticleId><ArticleId IdType="pubmed">22864911</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudkina N.V., Sunderhaus S., Braun H.-P. and Boekema E.J. (2006) Characterization of dimeric ATP synthase and cristae membrane ultrastructure from Saccharomyces and Polytomella mitochondria. FEBS Lett., 580, 3427&#x2013;3432. doi: 10.1016/j.febslet.2006.04.097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2006.04.097</ArticleId><ArticleId IdType="pubmed">16714019</ArticleId></ArticleIdList></Reference><Reference><Citation>Frezza C., Cipolat S., Martins de Brito O., Micaroni M., Beznoussenko G.V., Rudka T., Bartoli D., Polishuck R.S., Danial N.N., De Strooper and Scorrano L. (2006) OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell, 126, 177&#x2013;189. doi: 10.1016/j.cell.2006.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.06.025</ArticleId><ArticleId IdType="pubmed">16839885</ArticleId></ArticleIdList></Reference><Reference><Citation>Harner M., K&#xf6;rner C., Walther D., Mokranjac D., Kaesmacher J., Welsch U., Griffith J., Mann M., Reggiori F. and Neupert W. (2011) The mitochondrial contact site complex, a determinant of mitochondrial architecture. EMBO J., 30, 4356&#x2013;4370. doi: 10.1038/emboj.2011.379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.379</ArticleId><ArticleId IdType="pmc">PMC3230385</ArticleId><ArticleId IdType="pubmed">22009199</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoppins S., Collins S.R., Cassidy-Stone A., Hummel E., DeVay R.M., Lackner L.L., Westermann B., Schuldiner M., Weissman J.S. and Nunnari J. (2011) A mitochondrial-focused genetic interaction map reveals a scaffold-like complex required for inner membrane organization in mitochondria. J. Cell Biol., 195, 323&#x2013;340. doi: 10.1083/jcb.201107053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201107053</ArticleId><ArticleId IdType="pmc">PMC3198156</ArticleId><ArticleId IdType="pubmed">21987634</ArticleId></ArticleIdList></Reference><Reference><Citation>Paumard P., Vaillier J., Coulary B., Schaeffer J., Soubannier V., Mueller D.M., Br&#xe8;thes D., di Rago and Velours J. (2002) The ATP synthase is involved in generating mitochondrial cristae morphology. EMBO J., 21, 221&#x2013;230. doi: 10.1093/emboj/21.3.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/21.3.221</ArticleId><ArticleId IdType="pmc">PMC125827</ArticleId><ArticleId IdType="pubmed">11823415</ArticleId></ArticleIdList></Reference><Reference><Citation>von der Malsburg, M&#xfc;ller J.M., Bohnert M., Oeljeklaus S., Kwiatkowska P., Becker T., Loniewska-Lwowska A., Wiese S., Rao S., Milenkovic D. et al. (2011) Dual role of Mitofilin in mitochondrial membrane organization and protein biogenesis. Dev. Cell, 21, 694&#x2013;707. doi: 10.1016/j.devcel.2011.08.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2011.08.026</ArticleId><ArticleId IdType="pubmed">21944719</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehses S., Raschke I., Mancuso G., Bernacchia A., Geimer S., Tondera D., Martinou J.-C., Westermann B., Rugarli E.I. and Langer T. (2009) Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1. J. Cell Biol., 187, 1023&#x2013;1036. doi: 10.1083/jcb.200906084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200906084</ArticleId><ArticleId IdType="pmc">PMC2806285</ArticleId><ArticleId IdType="pubmed">20038678</ArticleId></ArticleIdList></Reference><Reference><Citation>Head B., Griparic L., Amiri M., Gandre-Babbe S. and van der Bliek (2009) Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells. J. Cell Biol., 187, 959&#x2013;966. doi: 10.1083/jcb.200906083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200906083</ArticleId><ArticleId IdType="pmc">PMC2806274</ArticleId><ArticleId IdType="pubmed">20038677</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand R., Wai T., Baker M.J., Kladt N., Schauss A.C., Rugarli E. and Langer T. (2014) The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. J. Cell Biol., 204, 919&#x2013;929. doi: 10.1083/jcb.201308006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201308006</ArticleId><ArticleId IdType="pmc">PMC3998800</ArticleId><ArticleId IdType="pubmed">24616225</ArticleId></ArticleIdList></Reference><Reference><Citation>Magri S., Fracasso V., Plumari M., Alfei E., Ghezzi D., Gellera C., Rusmini P., Poletti A., Bella D.D., Elia A.E., Pantaleoni C. and Taroni F. (2018) Concurrent AFG3L2 and SPG7 mutations associated with syndromic parkinsonism and optic atrophy with aberrant OPA1 processing and mitochondrial network fragmentation. Hum. Mutat., 39, 2060&#x2013;2071. doi: 10.1002/humu.23658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23658</ArticleId><ArticleId IdType="pubmed">30252181</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkwirth C., Dargazanli S., Tatsuta T., Geimer S., L&#xf6;wer B., Wunderlich F.T., von Kleist-Retzow, Waisman A., Westermann B. and Langer T. (2008) Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev., 22, 476&#x2013;488. doi: 10.1101/gad.460708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.460708</ArticleId><ArticleId IdType="pmc">PMC2238669</ArticleId><ArticleId IdType="pubmed">18281461</ArticleId></ArticleIdList></Reference><Reference><Citation>Wai T., Saita S., Nolte H., M&#xfc;ller S., K&#xf6;nig T., Richter-Dennerlein R., Sprenger H.-G., Madrenas J., M&#xfc;hlmeister M., Brandt U., Kr&#xfc;ger M. and Langer T. (2016) The membrane scaffold SLP2 anchors a proteolytic hub in mitochondria containing PARL and the i-AAA protease YME1L. EMBO Rep., 17, 1844&#x2013;1856. doi: 10.15252/embr.201642698.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201642698</ArticleId><ArticleId IdType="pmc">PMC5283581</ArticleId><ArticleId IdType="pubmed">27737933</ArticleId></ArticleIdList></Reference><Reference><Citation>MacVicar T.D.B. and Lane J.D. (2014) Impaired OMA1-dependent cleavage of OPA1 and reduced DRP1 fission activity combine to prevent mitophagy in cells that are dependent on oxidative phosphorylation. J. Cell Sci., 127, 2313&#x2013;2325. doi: 10.1242/jcs.144337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.144337</ArticleId><ArticleId IdType="pmc">PMC4021475</ArticleId><ArticleId IdType="pubmed">24634514</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson C.J., Bredvik K., Burstein S.R., Davis C., Meadows S.M., Dash J., Case L., Milner T.A., Kawamata H., Zuberi A. et al. (2019) ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response. Acta Neuropathol. (Berlin), 138, 103&#x2013;121. doi: 10.1007/s00401-019-01989-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01989-y</ArticleId><ArticleId IdType="pmc">PMC6571048</ArticleId><ArticleId IdType="pubmed">30877432</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin E.C., Madji Hounoum B., Bannwarth S., Fragaki K., Lacas-Gervais S., Mauri-Crouzet A., Lespinasse F., Neveu J., Ropert B., Aug&#xe9; G. et al. (2019) Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10S59L/+ mouse. Acta Neuropathol. (Berlin), 138, 123&#x2013;145. doi: 10.1007/s00401-019-01988-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01988-z</ArticleId><ArticleId IdType="pubmed">30874923</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J., Zhang K., Dong J., Yan C., Hu C., Ji H., Chen L., Chen S., Zhao H. and Song Z. (2020) Sam50-Mic19-Mic60 axis determines mitochondrial cristae architecture by mediating mitochondrial outer and inner membrane contact. Cell Death Differ., 27, 146&#x2013;160. doi: 10.1038/s41418-019-0345-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-019-0345-2</ArticleId><ArticleId IdType="pmc">PMC7206006</ArticleId><ArticleId IdType="pubmed">31097788</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine S., Kanamaru Y., Koike M., Nishihara A., Okada M., Kinoshita H., Kamiyama M., Maruyama J., Uchiyama Y., Ishihara N., Takeda K. and Ichijo H. (2012) Rhomboid protease PARL mediates the mitochondrial membrane potential loss-induced cleavage of PGAM5. J. Biol. Chem., 287, 34635&#x2013;34645. doi: 10.1074/jbc.M112.357509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.357509</ArticleId><ArticleId IdType="pmc">PMC3464569</ArticleId><ArticleId IdType="pubmed">22915595</ArticleId></ArticleIdList></Reference><Reference><Citation>Darshi M., Mendiola V.L., Mackey M.R., Murphy A.N., Koller A., Perkins G.A., Ellisman M.H. and Taylor S.S. (2011) ChChd3, an inner mitochondrial membrane protein, is essential for maintaining crista integrity and mitochondrial function. J. Biol. Chem., 286, 2918&#x2013;2932. doi: 10.1074/jbc.M110.171975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.171975</ArticleId><ArticleId IdType="pmc">PMC3024787</ArticleId><ArticleId IdType="pubmed">21081504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding C., Wu Z., Huang L., Wang Y., Xue J., Chen S., Deng Z., Wang L., Song Z. and Chen S. (2015) Mitofilin and CHCHD6 physically interact with Sam50 to sustain cristae structure. Sci. Rep., 5, 16064. doi: 10.1038/srep16064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16064</ArticleId><ArticleId IdType="pmc">PMC4632003</ArticleId><ArticleId IdType="pubmed">26530328</ArticleId></ArticleIdList></Reference><Reference><Citation>Floyd B.J., Wilkerson E.M., Veling M.T., Minogue C.E., Xia C., Beebe E.T., Wrobel R.L., Cho H., Kremer L.S., Alston C.L. et al. (2016) Mitochondrial protein interaction mapping identifies regulators of respiratory chain function. Mol. Cell, 63, 621&#x2013;632. doi: 10.1016/j.molcel.2016.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.06.033</ArticleId><ArticleId IdType="pmc">PMC4992456</ArticleId><ArticleId IdType="pubmed">27499296</ArticleId></ArticleIdList></Reference><Reference><Citation>Potting C., Tatsuta T., K&#xf6;nig T., Haag M., Wai T., Aaltonen M.J. and Langer T. (2013) TRIAP1/PRELI complexes prevent apoptosis by mediating intramitochondrial transport of phosphatidic acid. Cell Metab., 18, 287&#x2013;295. doi: 10.1016/j.cmet.2013.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.07.008</ArticleId><ArticleId IdType="pubmed">23931759</ArticleId></ArticleIdList></Reference><Reference><Citation>Rainbolt T.K., Atanassova N., Genereux J.C. and Wiseman R.L. (2013) Stress-regulated translational attenuation adapts mitochondrial protein import through Tim17A degradation. Cell Metab., 18, 908&#x2013;919. doi: 10.1016/j.cmet.2013.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.11.006</ArticleId><ArticleId IdType="pmc">PMC3904643</ArticleId><ArticleId IdType="pubmed">24315374</ArticleId></ArticleIdList></Reference><Reference><Citation>Russ W.P. and Engelman D.M. (2000) The GxxxG motif: a framework for transmembrane helix-helix association. J. Mol. Biol., 296, 911&#x2013;919. doi: 10.1006/jmbi.1999.3489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1999.3489</ArticleId><ArticleId IdType="pubmed">10677291</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter U., Lahtinen T., Marttinen P., Suomi F. and Battersby B.J. (2015) Quality control of mitochondrial protein synthesis is required for membrane integrity and cell fitness. J. Cell Biol., 211, 373&#x2013;389. doi: 10.1083/jcb.201504062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504062</ArticleId><ArticleId IdType="pmc">PMC4621829</ArticleId><ArticleId IdType="pubmed">26504172</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N.A., Nikkanen J., Yatsuga S., Jackson C., Wang L., Pradhan S., Kivel&#xe4; R., Pessia A., Velagapudi V. and Suomalainen A. (2017) mTORC1 regulates mitochondrial integrated stress response and mitochondrial myopathy progression. Cell Metab., 26, 419&#x2013;428.e5. doi: 10.1016/j.cmet.2017.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.07.007</ArticleId><ArticleId IdType="pubmed">28768179</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hl I., Miranda M., Atanassov I., Kuznetsova I., Hinze Y., Mourier A., Filipovska A. and Larsson N.-G. (2017) Transcriptomic and proteomic landscape of mitochondrial dysfunction reveals secondary coenzyme Q deficiency in mammals. eLife, 6, e30952. doi: 10.7554/eLife.30952.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.30952</ArticleId><ArticleId IdType="pmc">PMC5703644</ArticleId><ArticleId IdType="pubmed">29132502</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Wu B.P., Nguyen D., Liu Y.-T., Marani M., Hench J., B&#xe9;nit P., Kozjak-Pavlovic V., Rustin P., Frank S. and Narendra D.P. (2019) CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10. Hum. Mol. Genet., 28, 349. doi: 10.1093/hmg/ddy340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy340</ArticleId><ArticleId IdType="pmc">PMC6322067</ArticleId><ArticleId IdType="pubmed">30285108</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornelissen T., Spinazzi M., Martin S., Imberechts D., Vangheluwe P., Bird M., Strooper B. and Vandenberghe W. (2020) CHCHD2 harboring the Parkinson&#x2019;s disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2. Hum. Mol. Genet.. doi: 10.1093/hmg/ddaa028/5739952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa028/5739952</ArticleId><ArticleId IdType="pubmed">32068847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda A., Nishioka K., Meng H., Takanashi M., Hasegawa I., Inoshita T., Shiba-Fukushima K., Li Y., Yoshino H., Mori A. et al. (2019) Mutations in CHCHD2 cause &#x3b1;-synuclein aggregation. Hum. Mol. Genet., 28, 3895&#x2013;3911. doi: 10.1093/hmg/ddz241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz241</ArticleId><ArticleId IdType="pubmed">31600778</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallaro G. (2010) Genome -wide analysis of eukaryotic twin CX 9 C proteins. Mol. BioSyst., 6, 2459&#x2013;2470. doi: 10.1039/C0MB00058B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C0MB00058B</ArticleId><ArticleId IdType="pubmed">20922212</ArticleId></ArticleIdList></Reference><Reference><Citation>Auranen M., Ylikallio E., Shcherbii M., Paetau A., Kiuru-Enari S., Toppila J.P. and Tyynismaa H. (2015) CHCHD10 variant p.(Gly66Val) causes axonal Charcot-Marie-tooth disease. Neurol. Genet., 1, e1. doi: 10.1212/NXG.0000000000000003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000003</ArticleId><ArticleId IdType="pmc">PMC4821082</ArticleId><ArticleId IdType="pubmed">27066538</ArticleId></ArticleIdList></Reference><Reference><Citation>Longen S., Bien M., Bihlmaier K., Kloeppel C., Kauff F., Hammermeister M., Westermann B., Herrmann J.M. and Riemer J. (2009) Systematic analysis of the twin Cx9C protein family. J. Mol. Biol., 393, 356&#x2013;368. doi: 10.1016/j.jmb.2009.08.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2009.08.041</ArticleId><ArticleId IdType="pubmed">19703468</ArticleId></ArticleIdList></Reference><Reference><Citation>Quir&#xf3;s P.M., Ramsay A.J., Sala D., Fern&#xe1;ndez-Vizarra E., Rodr&#xed;guez F., Peinado J.R., Fern&#xe1;ndez-Garc&#xed;a M.S., Vega J.A., Enr&#xed;quez J.A., Zorzano A. and L&#xf3;pez-Ot&#xed;n C. (2012) Loss of mitochondrial protease OMA1 alters processing of the GTPase OPA1 and causes obesity and defective thermogenesis in mice. EMBO J., 31, 2117&#x2013;2133. doi: 10.1038/emboj.2012.70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.70</ArticleId><ArticleId IdType="pmc">PMC3343468</ArticleId><ArticleId IdType="pubmed">22433842</ArticleId></ArticleIdList></Reference><Reference><Citation>Karczewski K.J., Francioli L.C., Tiao G., Cummings B.B., Alf&#xf6;ldi J., Wang Q., Collins R.L., Laricchia K.M., Ganna A., Birnbaum D.P. et al. (2019) Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv, 531210. doi: 10.1101/531210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/531210</ArticleId></ArticleIdList></Reference><Reference><Citation>Korwitz A., Merkwirth C., Richter-Dennerlein R., Tr&#xf6;der S.E., Sprenger H.-G., Quir&#xf3;s P.M., L&#xf3;pez-Ot&#xed;n C., Rugarli E.I. and Langer T. (2016) Loss of OMA1 delays neurodegeneration by preventing stress-induced OPA1 processing in mitochondria. J. Cell Biol., 212, 157&#x2013;166. doi: 10.1083/jcb.201507022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201507022</ArticleId><ArticleId IdType="pmc">PMC4738383</ArticleId><ArticleId IdType="pubmed">26783299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wai T., Garc&#xed;a-Prieto J., Baker M.J., Merkwirth C., Benit P., Rustin P., Rup&#xe9;rez F.J., Barbas C., Iba&#xf1;ez B. and Langer T. (2015) Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice. Science, 350, aad0116. doi: 10.1126/science.aad0116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad0116</ArticleId><ArticleId IdType="pubmed">26785494</ArticleId></ArticleIdList></Reference><Reference><Citation>Fessler E., Eckl E.-M., Schmitt S., Mancilla I.A., Meyer-Bender M.F., Hanf M., Philippou-Massier J., Krebs S., Zischka H. and Jae L.T. (2020) A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol. Nature. doi: 10.1038/s41586-020-2076-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2076-4</ArticleId><ArticleId IdType="pmc">PMC7116715</ArticleId><ArticleId IdType="pubmed">32132706</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X., Aviles G., Liu Y., Tian R., Unger B.A., Lin Y.-H.T., Wiita A.P., Xu K., Correia M.A. and Kampmann M. (2020) Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway. Nature. doi: 10.1038/s41586-020-2078-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2078-2</ArticleId><ArticleId IdType="pmc">PMC7147832</ArticleId><ArticleId IdType="pubmed">32132707</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine S., Wang C., Sideris D.P., Bunker E., Zhang Z. and Youle R.J. (2019) Reciprocal roles of Tom7 and OMA1 during mitochondrial import and activation of PINK1. Mol. Cell, 73, 1028&#x2013;1043.e5. doi: 10.1016/j.molcel.2019.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.01.002</ArticleId><ArticleId IdType="pubmed">30733118</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann B., Wai T., Hu H., MacVicar T., Musante L., Fischer-Zirnsak B., Stenzel W., Gr&#xe4;f R., van den Heuvel, Ropers H.-H. et al. (2016) Homozygous YME1L1 mutation causes mitochondriopathy with optic atrophy and mitochondrial network fragmentation. eLife, 5. doi: 10.7554/eLife.16078.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.16078</ArticleId><ArticleId IdType="pmc">PMC4991934</ArticleId><ArticleId IdType="pubmed">27495975</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyanova S., Temu T. and Cox J. (2016) The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc., 11, 2301&#x2013;2319. doi: 10.1038/nprot.2016.136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2016.136</ArticleId><ArticleId IdType="pubmed">27809316</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>